HomePROGEN • STO
add
Prostatype Genomics AB
Previous close
kr 1.88
Day range
kr 1.60 - kr 1.89
Year range
kr 1.52 - kr 120.00
Market cap
9.14M SEK
Avg Volume
28.38K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 235.00K | -85.67% |
Operating expense | 5.19M | -23.69% |
Net income | -10.69M | 9.15% |
Net profit margin | -4.55K | -534.13% |
Earnings per share | — | — |
EBITDA | -10.23M | -0.02% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.42M | 251.23% |
Total assets | 41.97M | -14.73% |
Total liabilities | 8.50M | -65.37% |
Total equity | 33.47M | — |
Shares outstanding | 6.70M | — |
Price to book | 0.38 | — |
Return on assets | -63.89% | — |
Return on capital | -80.12% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -10.69M | 9.15% |
Cash from operations | -10.75M | -144.29% |
Cash from investing | -911.00K | 78.89% |
Cash from financing | 15.47M | 266.95% |
Net change in cash | 3.82M | 184.72% |
Free cash flow | -6.65M | 39.37% |
About
Founded
2007
Website
Employees
6
